Clinical Trial Disruptions and Patient Care

More than 50 years ago, President Richard Nixon declared war on cancer when he signed the National Cancer Act in 1971.

Since then, the United States has emerged as a juggernaut in cancer research, funded largely by the government.

But since President Donald Trump took office in January, the administration’s sweeping cuts to the federal workforce and government funding are upending the country’s research system.

So, how are these funding and staffing cuts affecting cancer research and treatment? And how could they impact our progress towards scientific breakthroughs?

Find more of our programs online. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a. 

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy